Back to Search
Start Over
Elacytarabine, a novel 5′-elaidic acid derivative of cytarabine, and idarubicin combination is active in refractory acute myeloid leukemia
- Source :
-
Leukemia Research . Apr2012, Vol. 36 Issue 4, pe71-e73. 0p. - Publication Year :
- 2012
Details
- Language :
- English
- ISSN :
- 01452126
- Volume :
- 36
- Issue :
- 4
- Database :
- Academic Search Index
- Journal :
- Leukemia Research
- Publication Type :
- Academic Journal
- Accession number :
- 72340557
- Full Text :
- https://doi.org/10.1016/j.leukres.2011.12.010